DART Diagnostics was created to improve diagnostics, bringing the benefits of recent nanomedicine discoveries to industrial pathogen detection. DART's technology can be integrated into classical immunoassays, massively improving them and allowing high sensitivity and early detection. Therefore, pathogens can be identified at low concentrations before their spread and/or, in the case of food industry applications, before food recalls are needed.
CEO: Ivo Martins